Results 131 to 140 of about 27,567 (340)

Comprehensive five-year study on salivary gland tumors: Demographic, clinical, and histopathological insights

Advances in Oral and Maxillofacial Surgery
Background: Salivary gland tumors account for 3 %–10 % of head and neck neoplasms. The aim of the study is to analyze demographic, clinical, and histopathological characteristics of salivary gland tumors.
Rahul Rajbhar, Dhanashri Ekatpure, Ashvini Kolhe   +2 more
doaj  

Educational Case: Diagnostic Approach to Salivary Gland Neoplasms. [PDF]

Acad Pathol, 2021
Malik P, Asiry S, Goldstein DY, Khader SN.   +3 more
europepmc   +1 more source

Malignant Salivary Gland Neoplasm [PDF]

, 2020

openalex   +1 more source

Efficacy of Eribulin Monotherapy in Patients With Unresectable and/or Metastatic Adenoid Cystic Carcinoma Receiving Platinum‐Based Therapy

Head &Neck, EarlyView.
ABSTRACT Background Adenoid cystic carcinoma (ACC) is the second most common and treatment‐resistant salivary gland carcinoma (SGC). Although platinum‐based therapies are effective, the efficacy of eribulin, a microtubule inhibitor with an 18% response rate in a Phase II trial involving recurrent/metastatic SGC, in patients with advanced ACC after ...
Tomomi Sanomachi, Tatsunori Shimoi, Yuki Kojima, Hideaki Takahashi, Motoko Arakaki, Asuka Kawachi, Hitomi Sumiyoshi Okuma, Mai Hoshino, Munehiro Ito, Ayumi Saito, Shosuke Kita, Aiko Maejima, Tadaaki Nishikawa, Kazuki Sudo, Taisuke Mori, Yasuhiro Fujiwara, Kan Yonemori   +16 more
wiley   +1 more source

Expanding the clinicopathological spectrum of TGFBR3-PLAG1 rearranged salivary gland neoplasms with myoepithelial differentiation including evidence of high-grade transformation. [PDF]

Genes Chromosomes Cancer, 2022
Rupp NJ, Höller S, Brada M, Vital D, Morand GB, Broglie MA, Huellner MW, Freiberger SN.   +7 more
europepmc   +1 more source

Conversion Surgery After Administration of a TRK Inhibitor for Unresectable Parotid Gland Secretory Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background The NTRK fusion gene is detected in most salivary gland secretory carcinomas. While tropomyosin receptor kinase (TRK) inhibitors are used for various solid tumors with the fusion gene, there are no reports regarding TRK inhibitor use for unresectable parotid gland carcinomas that subsequently shrink and become resectable.
Arisa Nagano, Takuma Matoba, Daisuke Kawakita, Kiyoshi Minohara, Sho Iwaki, Hiroshi Tsuge, Koji Tsukamoto, Sekai Kikuchi, Satsuki Nakano, Takayuki Murase, Yuichiro Tada, Shinichi Iwasaki   +11 more
wiley   +1 more source

Comparison of Diagnostic Reliability of p63 and Smooth Muscle Actin in Salivary Gland Neoplasms. [PDF]

Indian J Otolaryngol Head Neck Surg, 2022
Aswani E, Sherlin HJ, Jayaraj G, Don KR, Santhanam A.   +4 more
europepmc   +1 more source

Quad Shot—A Tertiary Hospital Experience With a Palliative Radiotherapy Regimen for Head and Neck Cancer

Head &Neck, EarlyView.
ABSTRACT Background Head and neck cancer patients often present with locally advanced disease. For some patients, palliative treatment schedules focused on symptom control are often preferred. Perhaps the most widely used of these is the so‐called Quad Shot (QS) regimen.
Eirini Nikolaidou, Tilman Bostel, Arnulf Mayer, Daniel Wollschläger, Heinz Schmidberger, Justus Kaufmann   +5 more
wiley   +1 more source

A Very Rare Salivary Gland Tumor: Sialoblastoma

Plastic and Reconstructive Surgery, Global Open
Summary:. Children seldom develop salivary gland tumors, which account for less than 5% of all salivary gland tumors. In total, 10%–15% of these neoplasms arise from the submandibular, sublingual, and small salivary glands, with the parotid gland ...
Dagmawi G. Zinaw, MD, Ataklitie B. Berhea, MD, FCS, ECSA, Endale K. Aydeferu, MD, Tigist D. Beyera, MD   +3 more
doaj   +1 more source

Mechanisms of enhancer‐driven oncogene activation

International Journal of Cancer, EarlyView.
Abstract An aggressive subtype of acute myeloid leukemia (AML) is caused by enhancer hijacking resulting in MECOM overexpression. Several chromosomal rearrangements can lead to this: the most common (inv(3)/t(3;3)) results in a hijacked GATA2 enhancer, and there are several atypical MECOM rearrangements involving enhancers from other hematopoietic ...
Joyce Vriend, Ruud Delwel, Dorien Pastoors   +2 more
wiley   +1 more source